BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kloster M, Ren A, Shah KY, Alqadi MM, Bui JT, Lipnik AJ, Niemeyer MM, Ray CE, Gaba RC. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation. Dig Dis Sci 2021;66:4058-62. [DOI: 10.1007/s10620-020-06716-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Luo X, Yang L. Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter. Dig Dis Sci 2021. [PMID: 33634428 DOI: 10.1007/s10620-021-06868-9] [Reference Citation Analysis]
2 Miraglia R, Maruzzelli L, Luca A. Transjugular Intrahepatic Portosystemic Shunt: A Single-Centre Mid-term Experience Using the Viatorr Controlled-Expansion Stent. Dig Dis Sci 2021. [PMID: 33638091 DOI: 10.1007/s10620-021-06867-w] [Reference Citation Analysis]
3 Li X, Partovi S, Coronado WM, Gadani S, Martin C, Thompson D, Levitin A, Kapoor B. Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management. Cardiovasc Intervent Radiol 2022. [PMID: 34981195 DOI: 10.1007/s00270-021-03045-3] [Reference Citation Analysis]
4 Chung KA, Pfeiffer RF. Gastrointestinal dysfunction in the synucleinopathies. Clin Auton Res 2021;31:77-99. [PMID: 33247399 DOI: 10.1007/s10286-020-00745-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]